Kobayashi M, Olefsky J M
J Clin Invest. 1978 Jul;62(1):73-81. doi: 10.1172/JCI109116.
We have tested the idea that the circulating plasma insulin level plays an important role in the long-term regulation, or maintenance, of the cellular glucose transport system, distinct from insulin's ability to acutely accelerate glucose transport. To study this hypothesis, groups of rats were made either hyperinsulinemic or hypoinsulinemic by daily insulin injections, or streptozotocin treatment, respectively. Different levels of hypoinsulinemia were produced by using different doses of streptozotocin (40 and 55 mg/kg). The mean (+/-SE) 9 a.m. plasma insulin level for each experimental group was: hyperinsulinemic animals, 65+/-5 muU/ml; controls, 32+/-3 muU/ml; low dose streptozotocin group, 18+/-3 muU/ml; and high dose streptozotocin group 5+/-2 muU/ml. Isolated adipocytes were prepared from each animal and glucose transport was assessed by measuring the initial rates of uptake of the nonmetabolyzable hexose 2-deoxy glucose. The V(max) and K(m) values for adipocyte glucose transport were calculated from the 2-deoxy glucose uptake data. The results demonstrated that in cells from control animals the V(max) of in vitro adipocyte glucose transport was 7.1+/-0.7 nmol/min per 10(6) cells in the basal state and 22.9+/-0.9 nmol/min per 10(6) cells in the presence of a maximally effective insulin concentration (25 ng/ml) in the buffer. In cells from the experimentally hyperinsulinemic animals these V(max) values were increased to 11.7+/-0.8 and 44.2+/-1.1 nmol/min per 10(6) cells. Using adipocytes from both groups of streptozotocin-treated (high dose, 55 mg/kg; low dose, 40 mg/kg) insulin-deficient diabetic animals, V(max) values were found to be progressively decreased. Thus, in the low dose group, basal-and insulin-stimulated V(max) values were 1.6+/-0.5 and 5.7+/-0.7 nmol/min per 10(6) cells, as compared to values of 0.9+/-0.2 and 1.7+/-0.6 in the high dose group. Thus, when considered as group data a positive relationship was found between circulating plasma insulin levels and adipocyte glucose transport V(max), with increased V(max) values in hyperinsulinemic rats and decreased V(max) values in hypoinsulinemic rats. Furthermore, when the individual data were analyzed, highly significant correlation coefficients were found between the height of the plasma insulin level and both the basal (r = 0.82, P < 0.001) and insulin-stimulated (r = 0.93, P < 0.001) V(max) values. The apparent K(m) for 2-deoxy glucose uptake was the same under all conditions. In conclusion, assuming that the V(max) of transport is some function of the number of glucose transport carriers per cell, then these results support the hypothesis that in addition to acute acceleration of glucose transport, insulin is also an important long-term regulator of the number of available adipocyte glucose transport carriers.
我们已经验证了这样一种观点,即循环血浆胰岛素水平在细胞葡萄糖转运系统的长期调节或维持中发挥重要作用,这一作用有别于胰岛素急性加速葡萄糖转运的能力。为了研究这一假说,分别通过每日注射胰岛素或链脲佐菌素处理,使大鼠组出现高胰岛素血症或低胰岛素血症。使用不同剂量的链脲佐菌素(40和55毫克/千克)产生不同程度的低胰岛素血症。每个实验组上午9点的平均(±标准误)血浆胰岛素水平为:高胰岛素血症动物,65±5微单位/毫升;对照组,32±3微单位/毫升;低剂量链脲佐菌素组,18±3微单位/毫升;高剂量链脲佐菌素组,5±2微单位/毫升。从每只动物制备分离的脂肪细胞,并通过测量不可代谢的己糖2-脱氧葡萄糖的初始摄取速率来评估葡萄糖转运。根据2-脱氧葡萄糖摄取数据计算脂肪细胞葡萄糖转运的V(max)和K(m)值。结果表明,在基础状态下,来自对照动物细胞的体外脂肪细胞葡萄糖转运的V(max)为每10⁶个细胞7.1±0.7纳摩尔/分钟,在缓冲液中存在最大有效胰岛素浓度(25纳克/毫升)时为每10⁶个细胞22.9±0.9纳摩尔/分钟。在实验性高胰岛素血症动物的细胞中,这些V(max)值分别增加到每10⁶个细胞11.7±0.8和44.2±1.1纳摩尔/分钟。使用两组链脲佐菌素处理(高剂量,55毫克/千克;低剂量,40毫克/千克)的胰岛素缺乏糖尿病动物的脂肪细胞,发现V(max)值逐渐降低。因此,在低剂量组中,基础和胰岛素刺激的V(max)值分别为每10⁶个细胞1.6±0.5和5.7±0.7纳摩尔/分钟,而高剂量组的值为0.9±0.2和1.7±0.6。因此,作为组数据考虑时,发现循环血浆胰岛素水平与脂肪细胞葡萄糖转运V(max)之间存在正相关关系,高胰岛素血症大鼠的V(max)值增加,低胰岛素血症大鼠的V(max)值降低。此外,当分析个体数据时,发现血浆胰岛素水平的高度与基础(r = 0.82,P < 0.001)和胰岛素刺激(r = 0.93,P < 0.001)的V(max)值之间存在高度显著的相关系数。在所有条件下,2-脱氧葡萄糖摄取的表观K(m)相同。总之,假设转运的V(max)是每个细胞葡萄糖转运载体数量的某种函数,那么这些结果支持以下假说,即除了急性加速葡萄糖转运外,胰岛素还是可用脂肪细胞葡萄糖转运载体数量的重要长期调节因子。